SPECIAL OFFER IN OUR STORE:
IF YOU PAY VIA YOU GET A DISCOUNT - 7%
5F-SDB-006 (also known as 5-fluoro-SDB-006) acts as a potent agonist for the cannabinoid receptors, with an EC50 of 50 nM for human CB1 receptors, and 123 nM for human CB2 receptors.
5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA. Given the known metabolic liberation of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-SDB-006 may release benzylamine.
5F-SDB-006 has formal name: N-Benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide. The chemical formula for 5F-SDB-006 is C21H23FN2O with a molecular weight of 338.43
5F-SDB- 006 similar effect to SDB-006.
The toxicity and long-term health effects of recreational 5F-SDB-006 use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown.
In our store Sale-Chemicals.com you can buy online pure 5F-SDB-006 in bulk, with free shipping and delivery guarantee. Here at Sale-Chemicals.com you can buy Research Chemicals in crystal, powder and liquid form.
5F-SDB-006 is intended for research and forensic purposes in a controlled laboratory for study only and is NOT intended for human consumption.
Buy 5F-SDB-006 wholesale online. We are the official manufacturer of research chemicals. Worldwide free shipping.
Free shipping 5F-SDB-006 in USA, Canada, Italy, United Kingdom, Brazil, Switzerland, Australia, New zeland, France, Germany, Japan, Russia, Mexico, Egypt, Turkey, Spain, Argentina, Poland, Morocco, Saudi Arabia, Austria, Romania, Kazakhstan, Netherlands, Belgium, Greece, Tunisia, Czech Republic, Dominican Republic, Portugal, Hungary, Israel, Bulgaria, Finland, Denmark, Slovakia, Norway, Ireland, Croatia, Armenia, Lithuania, Slovenia, Latvia, Estonia and many other countries.
On our site are not all the products that we sell. If you can not find on our website the product you are interested, please contact us, we will try to help you. Contact us...